Form D · Biotechnology
MDREJUVENA, INC.
San Diego, CA · CIK 0001623869
Offering snapshot reported Dec 19, 2016 · SEC filing
- Reported sold
- $2.42M Offering amount: $5M
- Investors reported
- 7 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 7, 2016 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 19, 2016 | Initial | $2,420,164 | No comparison | 7 | SEC filing |
| Oct 22, 2015 | Amendment | $3,799,723 | $3,549,723vs Nov 3, 2014 | 19 | SEC filing |
| Nov 3, 2014 | Initial | $250,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-276576
Source: Form D, filed Dec 19, 2016. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Rex D. Bright | Director |
| Michael Brower | Executive |
| Roegena Dunavant | Executive |
| Diane S. Goostree | Director |
| Vincent P. Gotz | Executive |
| David F. Hale | Director, Executive |
| Randy Kriech | Executive |
| Gerald T. Proehl | Director |
| William A. Roper | Director |
| Kathleen D. Scott | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
3525 Del Mar Heights Road Suite 609
San Diego, CA, 92130
San Diego, CA, 92130